miR-221 and -222 target CACNA1C and KCNJ5 leading to altered cardiac ion channel expression and current density

Azevedo PS, Polegato BF, Minicucci MF, Paiva SAR, Zornoff LAM (2016) Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol 106:62–69. https://doi.org/10.5935/abc.20160005 Fujiu K, Nagai R (2014) Fibroblast-mediated pathways in cardiac hypertrophy. J Mol Cell Cardiol 70:64–73. https://doi.org/10.1016/j.yjmcc.2014.01.013 Care A, Catalucci D, Felicetti F et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613–618. https://doi.org/10.1038/nm1582 van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575–579. https://doi.org/10.1126/science.1139089 Bartel DP (2004) MicroRNAs. Cell 116:281–297. https://doi.org/10.1016/S0092-8674(04)00045-5 Wang C, Wang S, Zhao P et al (2012) MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J Cell Biochem 113:2040–2046. https://doi.org/10.1002/jcb.24075 Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233. https://doi.org/10.1016/j.cell.2009.01.002 Bentwich I, Avniel A, Karov Y et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766–770. https://doi.org/10.1038/ng1590 Chen JF, Murchison EP, Tang R et al (2008) Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 105:2111–2116. https://doi.org/10.1073/pnas.0710228105 Zhao Y, Ransom JF, Li A et al (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303–317. https://doi.org/10.1016/j.cell.2007.03.030 Da Costa Martins PA, Bourajjaj M, Gladka M et al (2008) Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118:1567–1576. https://doi.org/10.1161/CIRCULATIONAHA.108.769984 Da Costa Martins PA, De Windt LJ (2012) MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 93:563–572. https://doi.org/10.1093/cvr/cvs013 Kontaraki JE, Marketou ME, Parthenakis FI et al (2015) Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension. J Am Soc Hypertens 9:802–810. https://doi.org/10.1016/j.jash.2015.07.013 Briasoulis A, Sharma S, Telila T, Mallikethi-Reddy S, Papageorgiou N, Oikonomou E, Tousoulis D (2017) MicroRNAs in atrial fibrillation. Curr Med Chem. https://doi.org/10.2174/0929867324666170920151024.:cmc-85906(CMC-EPUB-85906) Luo X, Pan Z, Shan H et al (2013) MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest 123:1939–1951. https://doi.org/10.1172/JCI62185 Lu Y, Zhang Y, Wang N et al (2010) MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122:2378–2387. https://doi.org/10.1161/CIRCULATIONAHA.110.958967 Schreier B, Rabe S, Schneider B et al (2013) Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy. Hypertension 61:333–340. https://doi.org/10.1161/HYPERTENSIONAHA.112.196543 Schreier B, Rabe S, Winter S et al (2014) Moderate inappropriately high aldosterone/NaCl constellation in mice: cardiovascular effects and the role of cardiovascular epidermal growth factor receptor. Sci Rep 4:7430. https://doi.org/10.1038/srep07430 Ding S, Huang H, Xu Y, Zhu H, Zhong C (2017) MiR-222 in cardiovascular diseases: physiology and pathology. Biomed Res Int 2017:4962426. https://doi.org/10.1155/2017/4962426 Kamkin A, Kiseleva I, Isenberg G (2003) Ion selectivity of stretch-activated cation currents in mouse ventricular myocytes. Pflugers Arch 446:220–231. https://doi.org/10.1007/s00424-003-1018-y Schreier B, Rabe S, Schneider B et al (2011) Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells. Hypertens Res 34:623–629. https://doi.org/10.1038/hr.2011.16 Robinson MD, Smyth GK (2008) Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9:321–332. https://doi.org/10.1093/biostatistics/kxm030 Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, Vilo J (2016) g: Profiler—a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res 44:W83–W89. https://doi.org/10.1093/nar/gkw199 Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinform 10:48. https://doi.org/10.1186/1471-2105-10-48 Braun J, Misiak D, Busch B, Krohn K, Hüttelmaier S (2014) Rapid identification of regulatory microRNAs by miTRAP (miRNA trapping by RNA in vitro affinity purification). Nucleic Acids Res 42:e66. https://doi.org/10.1093/nar/gku127 Xia M, Salata JJ, Figueroa DJ et al (2004) Functional expression of L- and T-type Ca2 + channels in murine HL-1 cells. J Mol Cell Cardiol 36:111–119. https://doi.org/10.1016/j.yjmcc.2003.10.007 Yang Z, Shen W, Rottman JN, Wikswo JP, Murray KT (2005) Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J Mol Cell Cardiol 38:299–308. https://doi.org/10.1016/j.yjmcc.2004.11.015 Deng C, Rao F, Wu S et al (2009) Pharmacological effects of carvedilol on T-type calcium current in murine HL-1 cells. Eur J Pharmacol 621:19–25. https://doi.org/10.1016/j.ejphar.2009.08.032 Canon S, Caballero R, Herraiz-Martinez A (2016) miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: implications in human chronic atrial fibrillation. J Mol Cell Cardiol 99:162–173. https://doi.org/10.1016/j.yjmcc.2016.08.012 Gidloef O, Smith JG, Miyazu K, Gilje P, Spencer A, Blomquist S, Erlinge D (2013) Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc Disord 13:12. https://doi.org/10.1186/1471-2261-13-12 Verjans R, Peters T, Beaumont FJ et al (2018) MicroRNA-221/222 family counteracts myocardial fibrosis in pressure overload-induced heart failure. Hypertension 71:280. https://doi.org/10.1161/HYPERTENSIONAHA.117.10094 Galindo CL, Skinner MA, Errami M et al (2009) Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiol 9:23. https://doi.org/10.1186/1472-6793-9-23 Tao H, Shi KH, Yang JJ, Li J (2016) Epigenetic mechanisms in atrial fibrillation: new insights and future directions. Trends Cardiovasc Med 26:306–318. https://doi.org/10.1016/j.tcm.2015.08.006 Chen Y, Wakili R, Xiao J (2014) Detailed characterization of microRNA changes in a canine heart failure model: relationship to arrhythmogenic structural remodeling. J Mol Cell Cardiol 77:113–124. https://doi.org/10.1016/j.yjmcc.2014.10.001 Teixeira AL, Gomes M, Medeiros R (2012) EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222. Front Genet 3:286. https://doi.org/10.3389/fgene.2012.00286.:286 Hauck L, Harms C, An J, Rohne J, Gertz K, Dietz R, Endres M, von Harsdorf R (2008) Protein kinase CK2 links extracellular growth factor signaling with the control of p27Kip1 stability in the heart. Nat Med 14:315–324. https://doi.org/10.1038/nm1729 Su M, Wang J, Wang C et al (2015) MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ 22:986–999. https://doi.org/10.1038/cdd.2014.187 Su M, Chen Z, Wang C et al (2016) Cardiac-specific overexpression of miR-222 induces heart failure and inhibits autophagy in mice. Cell Physiol Biochem 39:1503–1511. https://doi.org/10.1159/000447853 Di Leva G, Gasparini P, Piovan C et al (2010) MicroRNA cluster 221-222 and estrogen receptor α interactions in breast cancer. J Natl Cancer Inst 102:706–721. https://doi.org/10.1093/jnci/djq102 Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A (2009) Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284:3728–3738. https://doi.org/10.1074/jbc.M808788200 Corsten M, Heggermont W, Papageorgiou AP (2015) The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. Eur Heart J 36:2909–2919. https://doi.org/10.1093/eurheartj/ehv321 Schreier B, Huenerberg M, Mildenberger S et al (2018) Deletion of the EGF receptor in vascular smooth muscle cells prevents chronic angiotensin II-induced arterial wall stiffening and media thickening. Acta Physiol (Oxf). https://doi.org/10.1111/apha.12996 Hofmann F, Flockerzi V, Kahl S, Wegener JW (2014) L-type Cav1.2 calcium channels: from in vitro findings to in vivo function. Physiol Rev 94:303–326. https://doi.org/10.1152/physrev.00016.2013 Striessnig J, Pinggera A, Kaur G, Bock G, Tuluc P (2014) L-type Ca(2+) channels in heart and brain. Wiley interdiscip. Rev Membr Transp Signal 3:15–38. https://doi.org/10.1002/wmts.102 Foell JD, Balijepalli RC, Delisle BP, Yunker AM, Robia SL, Walker JW, McEnery MW, January CT, Kamp TJ (2004) Molecular heterogeneity of calcium channel β-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics 17:183–200. https://doi.org/10.1152/physiolgenomics.00207.2003 Thomsen MB, Wang C, Ozgen N, Wang HG, Rosen MR, Pitt GS (2009) Accessory subunit KChIP2 modulates the cardiac L-type calcium current. Circ Res 104:1382–1389. https://doi.org/10.1161/CIRCRESAHA.109.196972 Liao Y, Asakura M, Takashima S et al (2005) Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice. Cardiovasc Res 65:879–888. https://doi.org/10.1016/j.cardiores.2004.11.006 Semsarian C, Ahmad I, Giewat M et al (2002) The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest 109:1013–1020. https://doi.org/10.1172/JCI14677 Seisenberger C, Specht V, Welling A et al (2000) Functional embryonic cardiomyocytes after disruption of the L-type α1C (Cav 1.2) calcium channel gene in the mouse. J Biol Chem 275:39193–39199. https://doi.org/10.1074/jbc.M006467200 Goonasekera SA, Hammer K, Auger-Messier M (2012) Decreased cardiac L-type Ca(2+) channel activity induces hypertrophy and heart failure in mice. J Clin Invest 122:280–290. https://doi.org/10.1172/JCI58227 Zhao Y, Yuan Y, Qiu C (2016) Underexpression of CACNA1C caused by overexpression of microRNA-29a underlies the pathogenesis of atrial fibrillation. Med Sci Monit 22:2175–2181 Barana A, Matamoros M, Dolz-Gaiton P (2014) Chronic atrial fibrillation increases microRNA-21 in human atrial myocytes decreasing L-type calcium current. Circ Arrhythm Electrophysiol 7:861–868. https://doi.org/10.1161/CIRCEP.114.001709 Carrillo ED, Escobar Y, Gonzalez G, Hernandez A, Galindo JM, Garcia MC, Sanchez JA (2011) Posttranscriptional regulation of the β2-subunit of cardiac L-type Ca2+ channels by microRNAs during long-term exposure to isoproterenol in rats. JCardiovasc Pharmacol 58:470–478. https://doi.org/10.1097/FJC.0b013e31822a789b Napolitano C, Antzelevitch C (2011) Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res 108:607–618. https://doi.org/10.1161/CIRCRESAHA.110.224279 Bean BP (1985) Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. J Gen Physiol 86:1–30. https://doi.org/10.1085/jgp.86.1.1 McDonald TF, Pelzer S, Trautwein W, Pelzer DJ (1994) Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev 74:365–507. https://doi.org/10.1152/physrev.1994.74.2.365 Li XT, Li XQ, Hu XM, Qiu XY (2015) The inhibitory effects of Ca2+ channel blocker Nifedipine on rat Kv2.1 potassium channels. Plos One 10:2. https://doi.org/10.1371/journal.pone.0124602 Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90:291–366. https://doi.org/10.1152/physrev.00021.2009 Corey S, Clapham DE (1998) Identification of native atrial G-protein-regulated inwardly rectifying K+ (GIRK4) channel homomultimers. J Biol Chem 273:27499–27504. https://doi.org/10.1074/jbc.273.42.27499 Krapivinsky G, Gordon EA, Wickman K, Velimirovic B, Krapivinsky L, Clapham DE (1995) The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K+-channel proteins. Nature 374:135. https://doi.org/10.1038/374135a0 Hedin KE, Lim NF, Clapham DE (1996) Cloning of a xenopus laevis inwardly rectifying K+-channel subunit that permits GIRK1 expression of IKACh currents in oocytes. Neuron 16:423–429. https://doi.org/10.1016/S0896-6273(00)80060-4 Wickman K, Nemec J, Gendler SJ, Clapham DE (1998) Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20:103–114. https://doi.org/10.1016/S0896-6273(00)80438-9 Bang C, Batkai S, Dangwal S et al (2014) Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124(5):2136–2146. https://doi.org/10.1172/JCI70577